Equitec Proprietary Markets »

Gracell Biotechnologies shares owned by Equitec Proprietary Markets

Quarter-by-quarter ownership of Gracell Biotechnologies shares owned by Equitec Proprietary Markets from 13F filings

Historical chart of Equitec Proprietary Markets investment in Gracell Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Gracell Biotechnologies held by Equitec Proprietary Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gracell Biotechnologies by Equitec Proprietary Markets

Quarter filed Position value Share count Share price at filing
2023-12-31 $323k 32k 10.04

More positions owned by Equitec Proprietary Markets

United States Steel Corporation Call Option (X)
Super Micro Computer Call Option (SMCI)
Applied Digital Corp Com New (APLD)
NVIDIA Corporation (NVDA)
B. Riley Financial (RILY)
Capri Holdings SHS (CPRI)
Microstrategy Cl A New (MSTR)
Fusion Pharmaceuticals Call Option (FUSN)
Amedisys (AMED)
Brookfield Infrastructure Com Sb Vtg Shs A (BIPC)
Vizio Hldg Corp Cl A Com (VZIO)
Angel Oak Finl Strategies In Com Ben Int (FINS)
Cannae Holdings (CNNE)
Doubledown Interactive Co Lt Ads (DDI)
American Equity Investment Life Holding (AEL)

View all positions for Equitec Proprietary Markets

Top funds holding Gracell Biotechnologies

OrbiMed Advisors
Tang Capital Management
Baker Bros. Advisors
Pentwater Capital Management
TIG Advisors
Alpine Associates Management
Octagon Capital Advisors
Bank of America Corporation
LMR Partners
Sphera Funds Management
MMCAP International Inc. SPC
Hudson Bay Capital Management
Marshall Wace
Millennium Management
CNH Partners

View all funds holding Gracell Biotechnologies